Improve Addiction Education Act of 2017
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
63pct
16d open
vs 7,393 other HR bills in the 115th — cohort avg 50d
Improve Addiction Education Act of 2017 This bill amends the Controlled Substances Act to require a practitioner (other than a hospital, pharmacy, or veterinarian) to comply with a training or education requirement, as a condition of obtaining or renewing a registration to prescribe or dispense a controlled substance in schedule II or III for the treatment of pain or pain management.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2018 · fourth_quarter · Medical/Disease Research/Clinical Labs
Issues related to the promotion of continuing medical education (CME) and the implementation of the Physician Payment Sunshine Act. Implementation issues related to the Medicare Access and CHIP Reauthorization Act of 2015, P.L.114-10. Issues related to the role of continuing medical education (CME) and Food and Drug Administration (FDA) opioid REMS; SUPPORT for Patients and Communities Act (H.R.6/P.L.115-271); Opioid Prevention and Treatment Act of 2017 (H.R.993); Improve Addiction Education Act (H.R.4075); ADAPT Act (H.R.5581); REACH OUT Act (H.R.5796).
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Medical/Disease Research/Clinical Labs
Issues related to the promotion of continuing medical education (CME) and the implementation of the Physician Payment Sunshine Act. Implementation issues related to the Medicare Access and CHIP Reauthorization Act of 2015, P.L.114-10. Issues related to the role of continuing medical education (CME) and Food and Drug Administration (FDA) opioid REMS; SUPPORT for Patients and Communities Act (H.R.6); Opioid Prevention and Treatment Act of 2017 (H.R.993); Improve Addiction Education Act (H.R.4075); ADAPT Act (H.R.5581); REACH OUT Act (H.R.5796).
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Medical/Disease Research/Clinical Labs
Issues related to the promotion of continuing medical education (CME) and the implementation of the Physician Payment Sunshine Act. Implementation issues related to the Medicare Access and CHIP Reauthorization Act of 2015, P.L.114-10. Issues related to the role of continuing medical education (CME) and Food and Drug Administration (FDA) opioid REMS; SUPPORT for Patients and Communities Act (H.R.6); Opioid Prevention and Treatment Act of 2017 (H.R.993); Improve Addiction Education Act (H.R.4075); ADAPT Act (H.R.5581); REACH OUT Act (H.R.5796).
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2017 · fourth_quarter · Consumer Issues/Safety/Products
Cosmetics Regulation Consumer protection and product safety standards and regulations in cosmetics industry H.R. 575 Cosmetic Modernization Act, H.R. 4075
Client expense: Not reported · Firm income: $30,000
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2017 · third_quarter · Consumer Issues/Safety/Products
Cosmetics Regulation Consumer protection and product safety standards and regulations in cosmetics industry H.R. 575 Cosmetic Modernization Act, H.R. 4075
Client expense: Not reported · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2017 · third_quarter · Consumer Issues/Safety/Products
Legislation relating to Cosmetics Reform (chemical safety, cosmetic ingredient safety, and disclosure of fragrance ingredients in consumer products). HR 4075; S 1113, all provisions
Client expense: $80,000 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2017 · second_quarter · Consumer Issues/Safety/Products
Legislation relating to Cosmetics Reform (chemical safety, cosmetic ingredient safety, and disclosure of fragrance ingredients in consumer products). HR 4075; S 1113, all provisions
Client expense: $90,000 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2017 · second_quarter · Consumer Issues/Safety/Products
Consumer protection and product safety standards and regulations in cosmetics industry H.R. 575 Cosmetic Modernization Act, H.R. 4075
Client expense: Not reported · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2017 · first_quarter · Consumer Issues/Safety/Products
Consumer protection and product safety standards and regulations in cosmetics industry H.R. 575 Cosmetic Modernization Act, H.R. 4075
Client expense: Not reported · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2017 · first_quarter · Consumer Issues/Safety/Products
Cosmetics Reform (Introduced: HR 4075; Awaiting Introduction to 115th Congress: Personal Care Products Safety Act - Senate, Lance/Pallone - House) TSCA Implementation
Client expense: $80,000 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
| Republican |
| NY |
| Glenn Thompson | Republican | PA |
| Michelle Lujan Grisham | Democratic | NM |
| Thomas MacArthur | Republican | NJ |